Overview

A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Dry Eye Disease

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the safety and efficacy of azithromycin ophthalmic solution, 1% in dry eye subjects over a four week treatment period, using placebo as a comparison.
Phase:
Phase 4
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Azithromycin
Ophthalmic Solutions
Pharmaceutical Solutions